Publication | Closed Access

Aliskiren, an Oral Renin Inhibitor, Provides Dose-Dependent Efficacy and Sustained 24-Hour Blood Pressure Control in Patients With Hypertension

HypertensionCardiovascular DiseaseAntihypertensive AgentsAntihypertensive TherapyPharmacologyCardiovascular PharmacologyProvides Dose-dependent EfficacyBlood Pressure ControlOral Renin InhibitorPharmacotherapyMedicineBlood Pressure